Keep up to date with every new upload!

Join free & follow Cancer Network Podcasts
Share
  • 7 years ago
Bevacizumab Plus Chemotherapy in Patients With Early Stage HER2-Negative Breast Cancer

Bevacizumab Plus Chemotherapy in Patients With Early Stage HER2-Negative Breast Cancer

Dr. Gunter von Minckwitz discusses the recent paper he authored that showed that bevacizumab in addition to neoadjuvant chemotherapy significantly increased the rate of pathological complete response in patients with early stage HER2-negative breast cancer.

Comments